From November 6th to 9th, the 20th Annual Meeting of the Chinese Medical Doctor Association Dermatologists (CDA 2025) was successfully held. Chen Hong, Deputy General Manager of Tianjin Pharmaceutical Group and General Manager of Health Technology, and Sun Hongming, Deputy General Manager of Health Technology, led a team to participate in the exhibition. The company's series of dermatological drugs were showcased at the exhibition and received widespread attention.

As one of the largest and most influential academic events in the field of dermatology in China, the CDA Annual Meeting has always been an important platform for promoting the development of the discipline and clinical practice. Tianjin Pharmaceutical Group set up a special booth at this year's meeting, showcasing a variety of topical preparations, including hydrocortisone butyrate cream (Eucerin), diflucorrol valerate cream, halometasone cream (Eucerin), chlorhexidine hydroxyquine cream (Keailin), and compound cod liver oil zinc oxide ointment (Fuliping), as well as oral preparations such as prednisone tablets (Meilesong) and triamcinolone tablets (Aceton), attracting nearly a thousand attending experts and clinicians to stop and exchange ideas.

The experts at the meeting highly praised the skin medication family series products represented by hydrocortisone butyrate cream (Eucor), which further enhanced the company's professional image and market recognition in the field of dermatological treatment.

In the future, Tianjin Pharmaceutical Group will continue to strengthen its expert system and professional medical service capabilities, continuously improve product accessibility and brand influence, and continue to cultivate the field of dermatology treatment, providing clinicians and patients with better medication options.

Article by: Health Technology Company